Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 181 shares at $85.95 ($16K) on 2020-04-27, disclosed to the SEC on 2020-04-29.
Scheduled sale ($16k) by EVP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |
| ICPT | SELL | 2019-11-27 | $623K | — | Filing → |